002007 華蘭生物
按盤價 
15.600 +0.190 (+1.233%)
15.600 +0.190 (+1.233%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 3,378,886 | -3.20% | 4,379,197 | 5,341,873 | 4,516,979 | 4,436,200 | |
| 減：營業總成本 | 2,486,370 | 2.26% | 3,124,967 | 3,424,991 | 3,113,193 | 2,715,206 | |
| 其中:營業成本 | 1,429,887 | 7.15% | 1,688,241 | 1,624,478 | 1,532,865 | 1,386,880 | |
| 財務費用 | (783) | -91.35% | (6,843) | (1,672) | 9,679 | 9,809 | |
| 資產減值損失 | 12,277 | -- | (74,225) | (90,879) | (157,297) | (133,252) | |
| 公允價值變動收益 | 17,338 | -26.62% | 32,940 | 60,544 | 36,107 | 26,859 | |
| 投資收益 | 85,482 | -17.46% | 137,518 | 149,046 | 107,946 | 73,363 | |
| 其中：對聯營企業和合營企業的投資收益 | (25,073) | 22.87% | (26,440) | (25,645) | (26,407) | (13,932) | |
| 營業利潤 | 1,008,100 | -17.50% | 1,379,582 | 2,098,390 | 1,424,463 | 1,696,416 | |
| 利潤總額 | 972,414 | -18.88% | 1,338,613 | 2,077,643 | 1,428,368 | 1,688,245 | |
| 減：所得稅費用 | 144,713 | -22.86% | 183,143 | 315,958 | 180,765 | 234,128 | |
| 淨利潤 | 827,701 | -18.14% | 1,155,470 | 1,761,685 | 1,247,603 | 1,454,117 | |
| 減：非控股權益 | 43,278 | -50.54% | 67,619 | 280,106 | 171,338 | 155,220 | |
| 股東淨利潤 | 784,423 | -15.07% | 1,087,851 | 1,481,579 | 1,076,265 | 1,298,897 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.429 | -15.13% | 0.596 | 0.812 | 0.590 | 0.713 | |
| 每股派息 (元) * | 0.500 | -- | 0.200 | 0.300 | 0.300 | 0.200 | |
| 每股淨資產 (元) * | 6.223 | -2.71% | 6.485 | 6.211 | 5.700 | 4.570 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 25/11/2025 14:23 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
